Number of patients | 230 |
---|---|
Age, years (SD) | 71.1 (9.2) |
Men, n (%) | 142 (61.7) |
Women, n (%) | 88 (38.3) |
Diabetes duration, years (SD) | 10.4 (2.5) |
BMI, kg/m2 (SD) | 26.4 (1.8) |
Oral antidiabetic agents, n (%) | 130 (56.5) |
Insulin, n (%) | 171 (74.3) |
High blood pressure, n (%) | 165 (71.7) |
Hypercholesterolemia, n (%) | 149 (149) |
Smoking status | |
 Never smoked, n (%) | 63 (27.4) |
 Past smoker, n (%) | 90 (39.1) |
 Current smoker, n (%) | 77 (33.5) |
ABI (SD) | 0.63 (0.2) |
Rutherford staging | |
 Stage 4, n (%) | 106 (46.1) |
 Stage 5, n (%) | 124 (53.9) |
WIfI classification | |
 WIfI 010, n (%) | 45 (19.6) |
 WIfI 020, n (%) | 53 (23.0) |
 WIfI 110, n (%) | 64 (27.8) |
 WIfI 120, n (%) | 68 (29.6) |
Previous coronary artery disease, n (%) | 105 (45.7) |
Previous cerebrovascular disease, n (%) | 124 (53.9) |
Total cholesterol, mg/dL (SD) | 191.8 (28.2) |
LDL cholesterol, mg/dL (SD) | 113.2 (20.6) |
Triglycerides, mg/dL (SD) | 181.1 (27.3) |
Glucose, mg/dL (SD) | 120.7 (12.9) |
HbA1C, % (SD) | 8.9 (2.0) |
eGFR, mL/min/1.73Â m2 (SD) | 71.1 (12.8) |
Sortilin, ng/mL (SD) | 1.9 (0.6) |